Especially since that lying fraud said years ago it was effective.
Not only did Fauci reduce commentary on HCQ, after a brief mention he completely stopped making any reference at all to the ESSENTIAL VIRUS KILLER ZINC. He was probably aware of the cc sent to President Trump and Chief of Staff, Mark Meadows, on March 23, 2020, by Dr. Vladimir Zelenko. In this letter addressed to the medical community, Dr. Z explained the function of the 3 components and said that Zinc was the virus killer and very early treatment was essential. On May 14, 2020, NIH put out the following Press Release reported this: https://www.nih.gov/news-events/news-releases/nih-begins-clinical-trial-hydroxychloroquine-azithromycin-treat-covid-19
It was reported 2000 people were being enrolled to take part in this study. This quote is significant: “We urgently need a safe and effective treatment for COVID-19. Repurposing existing drugs is an attractive option because these medications have undergone extensive testing, allowing them to move quickly into clinical trials and accelerating their potential approval for COVID-19 treatment,” said NIAID Director Anthony S. Fauci, M.D. “Although there is anecdotal evidence that hydroxychloroquine and azithromycin may benefit people with COVID-19, we need solid data from a large randomized, controlled clinical trial to determine whether this experimental treatment is safe and can improve clinical outcomes.”
Significantly, this search for “solid data” did NOT include the ESSENTIAL VIRUS KILLER ZINC, and was only begun after a person had tested positive for the virus. Dr. Z urged starting treatment as soon as symptoms were observed. By the time the virus was tested, many more viruses had been produced in the body. So why did Dr. Fauci and NIH risk the lives of 2000 people with a study designed to fail?
“On the basis of as yet unpublished data, remdesivir “will be the standard of care” for patients with COVID-19, Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID), said during a press conference at the White House April 29.
The randomized, placebo-controlled international trial (on Remdesivir) was sponsored by NIAID, which is part of the National Institutes of Health, and enrolled 1,063 patients. It began on Feb. 21. https://www.covid19treatmentguidelines.nih.gov/panel-financial-disclosure/ shows that 7 of 60 listed scientists received “research support” from Gilead Sciences. While Dr. Fauci is not listed as receiving any direct financial support from Gilead Sciences, imagine how his bosses at NIH would react if, as the “face” of NIH, he suddenly began NOT supporting the research that NIH was heavily involved in?
NIAID conducts and supports research — at NIH, throughout the United States, and worldwide — to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782946/ When this article was first published (2006) the biomedical field was already changing rapidly and no doubt has continued to do so. The Remdesivir study shown above was called a Phase 2b study.
Here are described funds typically distributed in 2005: Phase I grant support, also known as a feasibility study, is normally funded at $100,000 for 6 months (SBIR) or $100,000 for 12 months (STTR). Phase II support is available to Phase I recipients and provides two-year awards of $750,000 (SBIR) or $500,000 (STTR). To foster the best quality applicants, the NIH SBIR program provides prospective applicants with a wealth of information, including advice documents4, free workshops and conferences5, and easy access to the program officials who can answer more in-depth questions.
Whether Fauci recieved direct payment or not, he certainly must have had pressure/incentive to do all he could to improve the NIH/Gilead Sciences relationship.
For those considering wrongful death and other suites, feel free to Private Reply me.